Recent Finacing
Recent Raise
Faze Medicines translates biomolecular condensate biology into therapeutics, conducting preclinical ALS and DM1 programs and using high-throughput screening, proteomics, and proprietary assays to identify condensate-regulating proteins and small-molecule inhibitors.
